Quality improvement of colonoscopy continues to be an important topic. This effort begins with creating detailed and accurate colonoscopy reports. Quality indicators are measurable endpoints that may be used in quality assurance and improvement plans. Key quality measures include cecal intubation rate, adenoma detection, withdrawal time, preparation quality, follow-up recommendations, and American Society of Anesthesiologists classification. Unresolved issues include establishing proper benchmarks, documenting the correlation between process measures and outcomes, aligning incentives to improved quality outcomes, and issues regarding access to quality data.
Documentation and measurement are essential to the Plan-Do-Study-Act model commonly used for quality improvement projects. Consequently, colonoscopy reports and performance measures are crucial to quality improvement programs and efforts aimed at maximizing the value of colonoscopy. In the past, however, colonoscopy reports garnered very little attention, and few measures of colonoscopy quality were endorsed. A growth in interest in colonoscopy quality has been paralleled with a growth in interest in these topics. Recently, societies and task forces have begun to advocate for standardized colonoscopy reports and to identify key performance measures (also known as quality indicators ) for colonoscopy. The use of precise and comprehensive colonoscopy reports and the regular assessment of quality indicators may lead to several rewards, including better patient outcomes, fewer complications, improved coordination of care, greater patient satisfaction, and improved reimbursement.
Colonoscopy reports
Role
Colonoscopy reports serve various different functions and are used by various different parties. First and foremost, the colonoscopy report is a clinical document. For the referring provider and other clinicians, the report renders diagnoses and recommended therapies, and the timing and interval for future examinations. The report may also help endoscopists prepare for future examinations through providing critical information about sedation and instrument requirements, response to bowel cleansing strategies, patient tolerance, and any complications. Second, the colonoscopy report can be used for quality assurance and improvement processes. Quality measurement information may be obtained, such as cecal intubation, quality of the preparation, and withdrawal time. Third, the colonoscopy report may have medicolegal implications. Fourth, colonoscopy reports are important for reimbursement. Inaccurate documentation of procedure indications or techniques used might translate into more time and effort spent obtaining reimbursement from payers.
Current State
Only a few studies have rigorously examined the quality of endoscopy reports, and most have shown incomplete reporting for several items. Robertson and colleagues examined reports from 122 endoscopy centers and found a substantial proportion of reports were missing key data, such as bowel preparation adequacy (70.5%), complications (41.8%), polyp size (26.2%), postprocedure recommendations (31.1%), sedation dose (27.1%), patient history (42.5%), and demographics (30.4%). More recently, Lieberman and colleagues queried 438,521 colonoscopy reports and also found that many were missing key data, including bowel preparation quality (13.9%), comorbidity classification (10.1%), description of cecal landmarks (14.7%), and polyp size (4.9%). Across practices, significant variation was seen in the inclusion of certain elements. For instance, the bowel preparation quality was missing in more than 20% of procedures at 14 of the 52 endoscopy centers. In another recent study, only 33.5% of reports included follow-up recommendations.
Colonoscopy Reporting and Data System
Recognizing that the absence of comprehensive and standardized colonoscopy reports has actually impeded quality measurement for colonoscopy, the Quality Assurance Task Group of the National Colorectal Cancer Roundtable developed the colonoscopy reporting and data system (CO-RADS) in 2007. The group modeled CO-RADS after work performed to standardize the reporting of other screening tests (mammography and CT colonography) and was developed with the expertise of individuals in gastroenterology, radiology, primary care, and health care delivery. The group had the goal of creating a system that included a colonoscopy report with standardized elements and terminology that would allow measurement of quality within and across practices. For each of the following items, CO-RADS identifies important subitems that should be specifically addressed.
Elements of a Quality Report
Patient demographics and history: age, gender, anticoagulation management plan, presence of intraventricular defibrillator device or pacemaker (and management plan)
Certain patient characteristics have a significant impact on the yield and safety of colonoscopy. The age and gender of a patient affect the risk of finding adenomas or colorectal cancer. Patients who require chronic anticoagulation or have implantable defibrillators or pacemakers are at higher risk for certain complications and deserve special attention. Other important preprocedure data includes documentation of informed consent and the type of facility where the colonoscopy is performed (eg, hospital, ambulatory surgery center or office).
Assessment of patient risk and comorbidity: American Society of Anesthesiologists classification
The American Society of Anesthesiologists (ASA) classification is one of the most commonly used risk assessment tools for colonoscopy. Although variability may exist between providers, the ASA has been used to predict perioperative mortality for many years and has been embraced by numerous specialties as a useful aid in measuring patient comorbidity. Furthermore, researchers have shown an association between preprocedure risk class and the rate of adverse events. Assessing a patient’s risk for complications is a process that may guide decisions regarding procedure setting, staff, and specific precautions.
Indications
Information about previous colonoscopies, along with risk factors, past medical history, and symptoms, help determine if and when a colonoscopy should be performed. Documentation of indications also provides a context for the procedure and explains why certain aspects of the procedure are performed or avoided (eg, not removing a tiny polyp during a procedure to treat hematochezia). This information should include information on the following:
- •
All indications: date of last colonoscopy, family history of colorectal cancer, adenomas, inherited syndrome
- •
Surveillance examinations: most advanced previous lesion, extent of last examination, adequacy of last bowel preparation
- •
Inflammatory bowel disease (IBD) surveillance: duration, extent, activity of disease; date of last examination; biopsy protocol used.
Procedure
Technical descriptions regarding the procedure should be documented, such as:
- •
Date and time
- •
Sedation: type, dose, provider responsible for sedation, level of sedation
- •
Extent of examination, reason incomplete (if applicable), method of verifying extent
- •
Time of examination: time when colonoscope inserted into rectum, when withdrawal from cecum started, when colonoscope was withdrawn from patient
- •
Performance of retroflexion
- •
Bowel preparation: type, dose, quality (adequacy to detect polyps >5 mm)
- •
Performance: difficulty, patient tolerance, special maneuvers
- •
Type of instrument: model and instrument number (could be reported in nursing record).
Bowel preparation has been shown to influence the sensitivity of colonoscopy for neoplasia detection. Furthermore, the quality of bowel preparation then influences the timing for surveillance examinations. Recognizing that qualitative assessments can be subjective, CO-RADS authors advocate a more objective assessment similar to that used in the field of CT-colonography: adequacy to detect lesions greater than 5 mm. Reaching the cecum and documenting cecal anatomy are important steps, because a substantial number of advanced adenomas and cancers are found in the proximal colon. Without information about the extent of the examination, whether the patient needs additional testing is unclear.
Several studies have shown an association between withdrawal time and detection of neoplastic lesions, but several caveats remain. The optimal withdrawal time is unknown; one group of authors investigated a 6-minute threshold and found a linear relationship between withdrawal time and adenoma detection (ADR), with no plateau in ADR. However, in another study, longer withdrawal time was not associated with higher rates of neoplasia detection. Although both the CO-RADS authors and the American Society for Gastrointestinal Endoscopy/American College of Gastroenterology (ASGE/ACG) Task Force on Quality in Endoscopy endorse measurement of withdrawal, the ASGE/ACG Task Force recommends measurement of withdrawal time primarily in settings of low adenoma detection. Whether withdrawal time should be documented on the colonoscopy report is not without controversy. A “short” withdrawal time on an individual report may lead to confusion because it may erroneously lead one to believe that the quality of a specific examination was suboptimal. Withdrawal times only have meaning when looked at in aggregate, as a mean, and as part of a quality assurance program.
The amount and type of sedation, patient tolerance, and overall difficulty of the examination may help in planning for future examinations. Instrument details must be recorded (either in the report or nursing records) to allow endoscope tracking if infection transmission is a concern.
Colonoscopic findings
Colonoscopic findings should be reported, including:
- •
Masses: location, size (in millimeters or centimeters), descriptors, biopsy, tattoo
- •
Polyps: location, size, morphology, biopsy or removal method, removal completion, retrieval, whether sent to pathology, tattoo
- •
Polyp cluster: same as for polyps, plus number in segment
- •
Submucosal lesions: same as for polyps
- •
Mucosal abnormality: suspected diagnosis, location, pathology obtained
- •
Other: diverticulosis, arteriovenous malformations, hemorrhoids, description of mucosa and whether biopsy performed in patients with diarrhea.
The effectiveness of colonoscopy for colorectal cancer screening depends on the identification and appropriate management of neoplastic lesions. The specific characteristics of a lesion influence the risk of recurrent lesions and are the basis of recommendations regarding the timing of future examinations. One particular polyp descriptor that was mentioned was the polyp size. Size plays a key role in determining intervals and size should be described in terms of millimeters, rather than vague qualitative terms.
Assessment
Impressions based on symptoms, laboratory studies, radiographic studies, and colonoscopic findings should be included in the report.
The assessment section of a colonoscopy report should incorporate clinical data from the colonoscopy within the context of the available data from the history and physical, laboratory values, and radiographic studies. Aside from these basic parameters, the CO-RADS group did not propose specific guidelines on the composition of the assessment section.
Interventions/unplanned events
Both immediate and delayed events/interventions should be recorded, including the type of event and the intervention used. Immediate events and interventions are obviously more easily recognized and reported, but delayed events (within 30 days) are also important, and include unplanned health visits or emergency department visits, hospitalization, blood transfusions, surgery, and death (including cause). Despite the difficulty, unplanned events should still be studied, and is easier when reports include complete and accurate information.
Follow-up plan
Various diagnostic and therapeutic recommendations may be made after colonoscopy. Patients only retain a fraction of medical information in medical encounters, and this fraction is likely to be less after administration of sedatives during colonoscopy. The colonoscopy report can relay important messages to referring physicians and help preserve continuity of care when it includes items such as:
- •
Future tests, referrals, medication changes, appointments
- •
Interval for follow-up colonoscopy (reason for nonguideline intervention)
- •
No further fecal occult blood testing for ≥5 years
- •
Communication to the patient and referring provider.
Pathology
A substantial proportion of colonoscopies include pathology specimens. Along with gross polyp descriptors, pathology of specimens also dramatically affect the timing of future examinations. Results should be reviewed and communicated to the referring provider and patient, along with a follow-up plan.
Performance measures
Defining and Measuring Quality
According to one industry survey, almost 90% of gastroenterologists already collect quality information or intend to do so soon. Assessment of quality and performance measures (or quality indicators), however, depends on how one defines quality. Health care professionals have traditionally defined quality in terms of the technical excellence of medical care and the nature of provider–patient interactions. Technical excellence consists of two aspects: the appropriateness of care and the skill with which care is provided. In essence, it is “doing the right thing right.” The nature of provider–patient interactions depends on clear communication, trust, concern, and sensitivity.
Although quality can be defined in various ways, quality measures have only three basic types: structure, process, and outcomes. Structure deals with the organizational infrastructure, including the facility and provider characteristics (eg, physician training and specialty). Processes are the components of care or steps taken by a provider to achieve some end point (eg, performing random biopsies for chronic diarrhea). Finally, outcomes refer to health status and are the result of structure and processes (eg, colonic perforation or adenoma detection).
Process Measures
Several features make process measures appealing. First, process measures are often clearly defined and simple, making them easier to measure than outcomes. Second, unlike outcome measures, process measures typically do not need to be adjusted for differences in patient characteristics. Third, when a good process measure is identified, it highlights a specific action or technique on which a provider can focus to improve health outcomes. Fourth, process measures are often more sensitive than outcome measures.
For example, two endoscopists may have dramatically different rates of cecal intubation but very similar rates of colon cancer detection. As this example illustrates, an outcome measure sometimes will not detect poor quality care even when poor quality care occurs. This scenario is more common when certain outcomes (eg, colon cancer detection) are relatively infrequent and a large number of encounters are required to calculate reliable estimates for their frequency.
Process measures also have limitations; they often have no intrinsic worth. A process measure is only useful if a clear link exists between the process and a clinically relevant outcome. Process measures face a test of validity and are not always accepted as meaningful by patients, providers, or payers. Additionally, individual process measures usually only assess one specific element of care, but do not yield a comprehensive evaluation of care.
Outcome Measures
Outcomes are more intuitive measures; they typically do have intrinsic worth and are often the purpose for the health care processes. These measures usually matter most to individual patients and purchasers of care. One of the major limitations of outcomes measures is the fact that patient characteristics can profoundly affect health outcomes. Thus, comparison of outcome measures across providers or groups often requires risk adjustment to ensure that differences in patient populations can be accounted for and valid comparisons can be made. For instance, adenoma detection can be influenced by age, gender, and quality of bowel preparation, among other things.
Because outcome measures are influenced by several factors other than a provider’s actions, providers will often have some degree of concern about the validity of outcome measures. Additionally, although health outcomes are the ultimate goal of care, measuring outcomes does not always provide physicians with specific targetable actions or steps they can address to improve. Also, certain outcomes are rare or a substantial delay occurs between care and health outcomes. For colonoscopy, perforations and colorectal cancers are too rare to offer meaningful comparisons until large sample sizes are amassed. Finally, although processes can often be collected easily during routine clinical care, outcomes data analysis often requires additional steps outside of the clinical encounter.
Ideal Measures
Rising health care costs and an emphasis on quality improvement have spurred discussion about characteristics of ideal quality measures across medicine, including gastroenterology. Colonoscopy quality measures are considered desirable if they are closely linked to relevant outcomes, evidence-based, auditable, easily integrated into practice, aimed at quality improvement (not cost-containment), and developed by a consensus process involving gastroenterology societies. Ideal measures should also be resistant to unintended consequences, and collection of measures should not be overly time-consuming. In 2006, the ASGE and the ACG formed the ASGE/ACG Task Force on Quality in Endoscopy and proposed a list of quality indicators for colonoscopy. These indicators are applied to three periods: preprocedure, which encompasses all contacts with the patient until sedation or scope insertion; intraprocedure, which encompasses scope insertion through withdrawal; and postprocedure, which encompasses recovery through follow-up.
Quality Measures for Colonoscopy
Preprocedure
Indication
The indication for colonoscopy should be documented and consistent with ASGE and U.S. Multi-Society Task Force on Colon Cancer indications. If a nonstandard indication is used, the rationale for this decision should be included.
When endoscopists perform colonoscopy for appropriate indications, they are more likely to make clinically relevant diagnoses. Still, research from Europe suggests the rate of inappropriate procedures is greater than 20% in some settings.
Informed consent
Consent with discussion of risks, benefits, and alternatives should be obtained from patients. Patients should be aware of potential risks before undergoing colonoscopy, including bleeding, infection, perforation, sedation adverse events, missed lesions, and intravenous site complications.
Postpolypectomy/postcancer resection surveillance intervals
Intervals between surveillance examinations after postpolypectomy and postcancer resection should follow recommended intervals.
Inflammatory bowel disease surveillance intervals
Intervals between surveillance examinations in patients with inflammatory bowel disease should follow recommended intervals. Current recommendations on intervals are aimed at achieving optimal balance between risks and benefits for colonoscopy. In the United States, survey data suggest that endoscopists often perform surveillance examinations at intervals that are shorter than those recommended in guidelines. Inappropriate timing for surveillance may occur more often when nongastroenterologists are performing the colonoscopy. In these instances, patients are subject to greater risk for complications with unclear clinical benefit.
Bowel preparation quality
All procedure notes should report the quality of the bowel preparation. The quality of a bowel preparation can affect cecal intubation and sensitivity of colonoscopy for neoplastic lesions (both large and small), and lead to repeat examinations. Poor quality preparations can decrease the effectiveness of colon cancer screening and increase the cost of medical care. Characteristics of the patient population being served may strongly influence the percentage of inadequate bowel preparations. However, the motivation and willingness of an endoscopist to take additional time to suction and avoid the need for a repeat examination may also be a factor. A systematic problem with bowel preparation instructions may lead to suboptimal rates of aborted and repeat procedures.
Intraprocedure
Cecal intubation
Reports should document cecal intubation and describe or photodocument cecal landmarks. The extent of the examination should be documented and cecal intubation should occur in 90% or more of all procedures and 95% or more of screening examinations in healthy adults (excluding procedures in which an endoscopist encounters severe colitis, poor preparation quality, severe diverticulosis, or clinical instability). Although these targets have been shown to be attainable, in some settings only 55% of endoscopists reached the cecum in 90% of cases, and as many as 9% reached the cecum less than 80% of the time.
ADRs
Among healthy asymptomatic individuals aged 50 or older who are undergoing screening colonoscopy, an adenoma should be detected in at least 25% of men and at least 15% of women.
More than 60% of colonoscopies in the United States are performed for screening or surveillance of neoplasia. The ADR is considered by the ASGE/ACG Task Force to be the “best neoplasia related indicator” and is one of the most studied quality indicators for colonoscopy. Studies have found variation in ADRs in a wide variety of settings. Colorectal cancers and advanced adenomas are obviously more important clinical outcomes than adenomas, but the ADR has been shown to correlate with the rate of detection of large adenomas, thereby reinforcing its clinical relevance. The ADR is perhaps one of the most commonly reported quality measures (albeit typically in academic or research settings), thereby providing substantial data to formulate benchmarks.
Withdrawal times
Mean withdrawal time should be 6 minutes or more in patients with intact colons and normal findings.
Rex conducted a study comparing withdrawal time during 10 consecutive procedures by two endoscopists (6 minutes, 41 seconds vs 8 minutes, 55 seconds) with known polyp detection rates, and this study led others to recommend a minimum of 6 minutes. In 2006, Barclay and colleagues found large variation in withdrawal times (3.1–16.8 minutes) among 12 gastroenterologists, and these correlated with variation in adenoma detection. In some settings, however, increasing withdrawal time does not translate into greater polyp yield. Measuring mean withdrawal time may be most appropriate for endoscopists with low rates of adenoma detection as a way to improve performance.
Biopsies for chronic diarrhea
Endoscopists should obtain random biopsies in patients with chronic diarrhea. The mucosa of patients with microscopic colitis often appears normal endoscopically. Diagnosing microscopic colitis requires biopsies, and without sampling normal-appearing mucosa, some cases would be missed. The best strategy for obtaining biopsies (with regard to number and distribution) is unclear, but obtaining proximal and distal colon biopsies increases the sensitivity for microscopic colitis.
Biopsy strategy for IBD surveillance
Four biopsies should be performed per 10-cm segment of affected colon.
Patients with endoscopic evidence of abnormalities such as scarring develop colon cancer at a higher rate than those without these abnormalities. In patients with IBD, a systematic approach to surveillance biopsies is necessary to optimize the detection of dysplasia. Following the strategy above results in approximately 32 biopsies for panulcerative colitis.
Endoscopic resection of polyps greater than 2 cm
Patients with mucosally based pedunculated polyps or sessile polyps smaller than 2 cm should have endoscopic resection attempted or documentation of endoscopic inaccessibility before surgical referral.
In the event of large polyps, endoscopists should attempt to remove polyps endoscopically instead of subjecting patients to surgery. If a difficult polyp is encountered, the endoscopist should obtain adequate photodocumentation and potentially refer the patient to a more experienced endoscopist or a surgeon if the lesion is truly inaccessible.
Postprocedure
Perforation incidence
The incidence of perforation should be measured and stratified according to indication.
Perforations are rare during colonoscopy, but approximately 5% of perforations that occur in colonoscopy are fatal. Based on previous studies, a perforation incidence of less than 1 per 500 for all colonoscopies and 1 per 1000 for screening colonoscopies is considered within reason. Although variation in rates of complications, such as perforation and bleeding exists, these indicators should be viewed with some caution. Perforations occur infrequently, and therefore precise estimates for each individual endoscopist may not be reliable. Patient risk factors and procedure complexity should also be taken into account.
Postpolypectomy bleeding
Incidence of postpolypectomy bleeding should be measured.
The most common complication of polypectomy is bleeding. Bleeding occurs in fewer than 1% of all cases of polypectomy but in approximately 10% of cases with polyps larger than 2 cm. Polyps that are more proximal also have a higher likelihood of bleeding.
Management of postpolypectomy bleeding
In the event of continued postpolypectomy bleeding, endoscopic evaluation and management should occur.
When postpolypectomy bleeding occurs, more than 90% of cases can be managed without surgery. Most bleeding will stop spontaneously, but some patients may require a repeat colonoscopy with placement of clips, or injection with cautery.
Reasons for Variation in Quality
Many studies have focused on documenting the existence of variation in colonoscopy quality, but the reasons for this variation have not been clear. Retrospective studies have shown associations between cecal intubation and several factors, including bowel preparation quality, sedation type, colonoscopy setting, and endoscopist factors such as volume and years in practice. Others have retrospectively analyzed polyp detection rates and found associations with bowel preparation quality and sedation, among other factors. Some of the variability is certainly due to patient-related factors (eg, demographics, family history) and procedure-related factors (bowel preparation quality, sedation), but a substantial fraction of the variability is also related to endoscopist performance. As a result, quality improvement projects have investigated patient-related changes, organizational arrangements, and endoscopist-related interventions.
Impact of Measurement: Internal Audits and Organizational Changes
In 2004, Ball and colleagues reported one of the first prospective quality improvement projects for colonoscopy. Hoping to improve cecal intubation rates, members of an endoscopy unit in the United Kingdom audited colonoscopy reports over two periods to determine reasons for incomplete examinations. The strategy during the first audit included increasing appointment duration from 20 to 30 minutes, and hospitalization of frail patients for their bowel preparation. This practice led to an increase in cecal intubation rate from 60% to 71.2%. The strategy developed during the second audit included assigning more colonoscopies to the endoscopists with higher cecal intubation rates and having less-successful endoscopists receive further training or stop performing colonoscopies. The group increased their completion rate to 88.1% of all procedures and 93.8% of procedures without a poor bowel preparation, stricture, or obstruction. Not only did the department as a whole improve, but also all of the individual endoscopists who continued to do procedures improved. Although many of the changes were organizational, the authors thought the process of auditing itself also influenced performance.
Imperiali and colleagues used a similar approach to that used by Ball and colleagues, examining a quality improvement project in Italy. They performed six monthly audit cycles from 2001 to 2005. The audits included departmental meetings to discuss standards, review the results of the audit, and develop action plans. Individual endoscopists were informed about their own performance only. One intervention included giving preprocedure sedation instead of on-demand sedation for patients. An approach that differed from the one used by Ball and colleagues was the practice of having more endoscopy sessions for endoscopists with lower performance rates or less experience. The less-skilled endoscopists were also randomly supervised by more-experienced endoscopists, and endoscopists with low polyp detection rates had a personal interview with the head of the unit to discuss the importance of polyps and technical aspects of examination. Additionally if an endoscopist was unable to intubate the cecum, a second endoscopist was instructed to attempt to intubate the cecum, if possible.
Over the study period, the cecal intubation rate increased from 84.6% to 93.1%. The overall polyp detection rate remained about the same, but the range in polyp detection among individual endoscopists decreased. They also acknowledged the possibility that the audit process itself may have been responsible for much of the improvement and reported a slight decrease in cecal intubation during a period when endoscopists were unaware that examinations had been reviewed.
Colonoscopy Technique and Feedback
Harewood and colleagues investigated the issue of feedback on cecal intubation, insertion time, and withdrawal time. On a quarterly basis for almost a year, 58 endoscopists received e-mails communicating their performance and rank compared with their colleagues. The cecal intubation rate increased from 95.3% to 96.2% and insertion time decreased from 10.6 to 9.5 minutes, whereas median withdrawal times did not change significantly. In addition to the e-mails, the group postulated that discussions at divisional meetings may have reinforced the importance of slow withdrawal and careful inspection. They also raised the issue of durability, noting that some of the trends started to reverse toward the end of the study period.
In 2008, Barclay and colleagues investigated a novel quality improvement intervention that involved an emphasis on both withdrawal time and inspection technique. To achieve an 8-minute withdrawal time, they used a digital stopwatch that emitted an audible sound signifying 2-minute increments. To address the issue of inspection technique, the group discussed an article describing techniques (insufflation, suction, inspection of flexures, proximal sides of folds, withdrawal time) and solicited the advice of endoscopists in the group with high ADRs. After the intervention, endoscopists increased the rate of neoplasia detection from 23.5% to 34.7%, which included an approximately 50% increase in the percentage of subjects with at least one adenoma and a 45% increase in the number of advanced adenomas per subject screened. Despite the apparent improvements, the authors found that the endoscopists with the highest ADRs had only intermediate withdrawal times. A retrospective study by other authors failed to identify an increase in polyp detection, using a 7-minute withdrawal protocol.
In one of the largest studies to address the issue of performance improvement, Shaukat and colleagues found that various interventions did not appear to change endoscopists’ adenoma detection rates. The authors prospectively collected data on 47,253 screening colonoscopies over 3 years, while instituting five interventions. Interventions included ADR review (blinded and unblinded), education about ADR benchmarks and withdrawal time, discussions between poor performing endoscopists and practice leaders, and financial consequences of not achieving a 6-minute withdrawal time in greater than 95% of colonoscopies.
Although some of the studies above show some improvement, uncertainty still exists regarding the optimal approach to improve endoscopist performance. Elements of inspection thought to impact neoplasia detection include ample insufflation, meticulous evaluation of flexures and proximal sides of folds, adequate suctioning of retained fluid, and withdrawal duration. Recently, operator motivation and fatigue have been suggested as additional factors affecting the yield of colonoscopy. Aside from withdrawal times, most of these features are too ambiguous or difficult to quantify and measure consistently. Furthermore, even if a measure is selected, the optimal frequency and format for feedback is unclear. Finally, if improvements are made, the improvements may not be durable or long-lasting.
High-priority Measures
Although the perfect quality measure does not exist, several measures seem to be particularly useful for improving the quality of colonoscopy: (1) cecal intubation rate, (2) adenoma detection rate, (3) withdrawal time, (4) preparation quality, (5) follow-up recommendations, and (6) ASA classification.